BioPharma Credit increases size of share sale

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Equity IPOs

BioPharma Credit increases size of share sale

Sam Kerr
October 24, 2018 02:15 pm
Pharma,

BioPharma Credit, the UK closed-end investment fund that provides debt capital to the life sciences industry, has increased the size of a primary share offering by $50m to $200m

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsEquityUKEuropeEMEASRI
SK
Sam Kerr
Gift this article